NCT00834002View on ClinicalTrials.gov

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2008

Conditions
Acute Myeloid Leukemia (AML)
Interventions
BIOLOGICAL

injection of antigen-loaded cultured dendritic cells

intradermal injection of WT1-RNA-electroporated autologous dendritic cell vaccine (therapeutic cell vaccine)

Trial Locations (1)

2650

Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER

NCT00834002 - Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission | Biotech Hunter | Biotech Hunter